TP53 and cancer: In addition, the mechanism underlying the anti-cancer activity of BP-LCNs was analyzed by determining the regulatory role of BP-LCNs on KRT18, PTEN, and P53 mRNA levels and the expression of proteins associated with the proliferation and cell migration or cancer metastasis.